Paris, February 7, 2019 Sanofi delivers 2018 business EPS growth of 5.1% at CER ...
Providing the largest source of standardized, multi-omic immune data from healthy human subjects to ...
Symphogen Further Strengthens its Immuno-Oncology Pipeline by Advancing into Two Additional Clinical Trials Seventh ...
